catalog number :
MBS592004
products full name :
mAb anti-Human Hepatocellular Carcinoma
products short name :
[Hepatocellular Carcinoma]
products name syn :
[Hepatocellular Carcinoma; Mouse monoclonal antibody to human hepatocellular carcinoma]
reactivity :
Human. Others not tested. There were no detectable positive reactions with other human tumor cell lines and solid tumour specimens. Showed negative reaction to all normal human adult tissues and fetal tissues tested.
specificity :
Using indirect immunofluorescence assay, this MAb showed positive reactions with 8 human hepato-cellular carcinoma cell lines and 12 human liver cancer surgical specimens tested. Hepatocellular Carcinoma
purity :
Protein G affinity purified
form :
Lyophilized from a solution in 0.01M PBS, pH7.0
storage stability :
Store at -20°C
tested application :
Indirect Immunofluorescence assay
other info1 :
Target Protein: Human hepato-cellular carcinoma related protein. Immunogen: Human liver carcinoma cells. Myeloma: Sp2/0-Ag14. Light Chain: Kappa. Reconstitution: Double distilled water is recommended to adjust the final concentration to 1.00mg/mL.
other info2 :
Research Area: Oncology
products categories :
Primary antibodies; Monoclonal Antibodies to Human Tumor Markers
products description :
Mouse monoclonal antibody to human hapatocellular carcinoma. Hepatocellular carcinoma frequently occurs in individuals infected with hepatitis virus B and/or C, and in alcoholic persons with cirrhosis. In countries where hepatitis is not epidemic, hepatocellular carcinoma is mostly metastatic cancers developed elsewhere in the body. At early stage, the cancer can be curable by surgical removal of small tumour if liver is in good condition or by transplantation if liver’s function is damaged because of disease. The cancer responds poorly to treatment at advanced stage.